- Regen BioPharma entered into an equity line agreement with Coventry Enterprises for up to $10 million.
- Issued a $125,000 10% unsecured promissory note with a $12,500 original issue discount.
- Dilution risk from continuous stock issuances under the equity facility.
?? Negative AI Sentiment (-4.0 / 10)